Dra. Tri Asti Isnariani, Apt, M.Pharm.
Tri Asti Isnariani was born in Sigli on April 14, 1969. Since September 29, 2025, she has served as the Director of Drug Registration, having previously led the Directorate of Standardization for Drugs, Narcotics, Psychotropics, Precursors, and Addictive Substances (2022–2025). A graduate of the Pharmacy and Pharmacist Professional programs at ITB, she earned a Master of Pharmacy (Clinical Pharmacy) degree from the University of Science Malaysia in 1999. She is active in national and international forums, serving roles such as Chair of ACCSQ-PPWG (2022–2023) and Chair of SEARN WG2 (2023–2024), acting as the Focal Point for the Indo-Pacific Regulatory Strengthening Program, and speaking at forums including IEU-CEPA and the APAC Health and Life Sciences Summit 2025. In recognition of her dedication, she has received the Satya Lancana Karya Satya awards (10-year and 20-year service honors in 2016 and 2023, respectively) and the "Pioneer of Integrity Zone Change" award (2019). The submission of the State Official Wealth Report (LHKPN) demonstrates the Director of Drug Registration's commitment to the principles of transparency, accountability, and integrity. Compliance with LHKPN reporting supports the development of an Integrity Zone and strengthens governance characterized by cleanliness, professionalism, and a public service orientation. In the interest of public information transparency, the LHKPN document for the Director of Drug Registration is accessible via the link below. Please click the following link to view the Director of Drug Registration's LHKPN document.
